Rebyota

Indicated For

recurrent Clostridioides difficile infection, CDI recurrence prevention

About This Medication

# Rebyota Patient Assistance Program: How to Get Rebyota at Low or No Cost ## About Rebyota Rebyota (fecal microbiota, live-jslm) is a prescription medication manufactured by Ferring Pharmaceuticals. It is the first and only single-dose fecal microbiota transplant (FMT) approved by the U.S. Food and Drug Administration (FDA) for preventing recurrent Clostridioides difficile infection (rCDI) in adults.[2] Real-world clinical data shows that 75% of patients receiving Rebyota achieved treatment success with no CDI recurrence at 8 weeks, and patients reported improvements in their health-related quality of life.[2] ## Who Qualifies for This Program The Rebyota Patient Assistance Program is designed to help patients access this medication at reduced or no cost. You may be eligible if you are: - **Uninsured**: You have no health insurance coverage - **Underinsured**: You have health insurance but face financial hardship in affording Rebyota - **Commercially insured**: You have private insurance and meet financial need criteria - **Government insurance beneficiaries**: You have Medicare, Medicaid, or other government coverage and can receive assistance through the end of the calendar year The program is **needs-based**, meaning eligibility is determined by your financial situation rather than strict income cutoffs. You must be a resident of the United States or Puerto Rico to qualify.[3] ## Income Eligibility The program does not publish specific income thresholds. Instead, eligibility is assessed on a case-by-case basis considering your overall financial need. When you apply, you will need to demonstrate that you have limited financial resources to afford Rebyota. The program evaluates factors such as: - Your household income - Your employment status - Your existing medical expenses - Your ability to pay for the medication If you are unsure whether you qualify, contact the program directly at 1-877-REBYOTA (1-877-732-9682) Monday through Friday, 8 a.m. to 8 p.m. EST. Program representatives can discuss your situation confidentially and help determine your eligibility. ## Insurance Requirements and Coverage Details The program accepts patients with various insurance statuses: | Insurance Type | Eligibility | Duration of Assistance | |---|---|---| | Uninsured | Yes | Ongoing (needs-based) | | Underinsured | Yes | Ongoing (needs-based) | | Commercially insured | Yes (if financially needy) | Up to 12 months | | Government insurance (Medicare, Medicaid) | Yes | Through end of calendar year | If you have government insurance, your assistance ends on December 31st of the current year. You may need to reapply the following year if you continue to need support. If you have commercial insurance, assistance is available for up to 12 months and may be renewable based on continued financial need.[3] ## How to Apply: Step-by-Step Instructions **Step 1: Gather Required Documents** You will need: - A completed enrollment form (provided by the program) - Your healthcare provider's (HCP) completed enrollment form - Documentation of your financial need (such as recent pay stubs, tax returns, or proof of unemployment) - Your insurance information (if applicable) - Proof of residency in the US or Puerto Rico **Step 2: Complete the Enrollment Form** Obtain the Rebyota Patient Assistance Program enrollment form from your healthcare provider or by calling 1-877-REBYOTA. Complete all sections of the form with accurate information about your household income, family size, and financial situation. Your healthcare provider must also complete their portion of the form. **Step 3: Submit Your Application** Fax your completed enrollment form and supporting documents to: **1-877-778-7167** Make sure all pages are legible and include your contact information. Keep a copy for your records. **Step 4: Wait for Approval** The program will review your application and contact you to confirm approval status. Processing times are not publicly specified, so contact the program if you have not heard back within 2-3 weeks. **Step 5: Receive Your Medication** Once approved, Rebyota will be provided at no cost. The medication will either be: - **Shipped directly to your healthcare provider's site of administration**, or - **Reimbursed** if the medication has already been administered and invoiced Your healthcare provider will coordinate the delivery or reimbursement process. ## Timeline and What to Expect While the program does not publish specific processing timelines, you should expect: - **Application submission**: Fax your completed form to 1-877-778-7167 - **Review period**: Allow 2-3 weeks for the program to review your application - **Approval notification**: The program will contact you by phone or mail - **Medication delivery**: Once approved, Rebyota will be shipped to your provider's office or reimbursement will be processed For faster assistance or to check on your application status, call 1-877-REBYOTA Monday through Friday, 8 a.m. to 8 p.m. EST. ## What Happens If Your Application Is Denied If your application is denied, you have several options: 1. **Request reconsideration**: Ask the program to review your application if your financial situation has changed or if you believe additional information supports your eligibility 2. **Contact your healthcare provider**: Your provider may be able to appeal on your behalf or provide additional documentation 3. **Explore other assistance**: Ask your provider about other patient assistance programs, hospital financial aid programs, or nonprofit organizations that help with medication costs 4. **Contact Ferring directly**: Call 1-877-REBYOTA to discuss alternative options ## Reauthorization and Renewal The Rebyota Patient Assistance Program requires **reauthorization** for continued assistance. Here's what you need to know: - **Commercial insurance**: Assistance is available for up to 12 months and may require reauthorization if you need continued support beyond that period - **Government insurance**: Assistance is available through the end of the calendar year; you must reapply in January if you need continued support - **Uninsured/underinsured**: Reauthorization requirements depend on your specific circumstances; contact the program to confirm The program will notify you when reauthorization is needed. You may need to submit updated financial information to demonstrate continued need. ## Important Disclaimer This guide provides general information about the Rebyota Patient Assistance Program based on publicly available information as of March 2026. Program details, eligibility requirements, and benefits may change at any time. Always verify current program details by contacting Ferring Pharmaceuticals directly at 1-877-REBYOTA or consulting with your healthcare provider. This information is not a guarantee of eligibility or assistance. Individual circumstances vary, and the program makes final determinations on all applications.

Program information last verified: March 30, 2026